Pharmafile Logo
Pharmafocus logo
Advanced Search

cardiometabolic diseases

Showing 3 posts of 3 posts found.

Julius Clinical appoints Bassem Saleh as CEO

October 16, 2025
Julius Clinical, cardiometabolic diseases, central nervous system

Julius Clinical, a Netherlands-based clinical research organisation (CRO), has appointed Bassem Saleh as its new chief executive officer (CEO). Saleh …

Appointment

Rybelsus found to reduce major adverse cardiovascular events in Novo Nordisk trial

April 1, 2025
Research and Development Cardiology, Novo Nordisk, cardiometabolic diseases, research and development

Novo Nordisk announced results from its SOUL cardiovascular outcomes trial. Rybelsus (oral semaglutide) significantly reduced the risk of major adverse …

News

Eli Lilly to acquire Versanis Bio for $1.9bn

July 17, 2023
Sales and Marketing Cardiology, Eli Lilly, Versanis Bio, acquisition, cardiometabolic diseases

Eli Lilly and Versanis Bio have announced a definitive agreement for Lilly to acquire Versanis, a private clinical-stage biopharmaceutical company …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about the menopause

March 6, 2026

Zello Appoints Kevin Bailey as Group Chief Medical Officer

March 6, 2026

BioDuro establishes joint manufacturing venture with Cenra

March 6, 2026

Symbiosis appoints Joanne Anderson as Chief Commercial Officer

March 6, 2026

Secarna Pharmaceuticals and Curie.Bio expand existing partnership

March 6, 2026